89 related articles for article (PubMed ID: 26189636)
21. [A resected case of recurrent intrahepatic cholangiocellular carcinoma with a cholangiocellular carcinoma component after transcatheter arterial embolization and radiofrequency ablation].
Shibuya K; Ishizu H; Watarai H; Takahashi M; Omura T; Ichihara S
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2003-5. PubMed ID: 23267957
[TBL] [Abstract][Full Text] [Related]
22. Cholangiolocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction.
Sempoux C; Fan C; Singh P; Obeidat K; Roayaie S; Schwartz M; Fiel MI; Thung SN
Semin Liver Dis; 2011 Feb; 31(1):104-10. PubMed ID: 21344355
[TBL] [Abstract][Full Text] [Related]
23. [An autopsy case with a combination of hepatocellular carcinoma and cholangiocellular carcinoma].
Sugihara S; Nakahara T; Maruiwa M; Kojiro M; Iwai I; Tanaka M; Hirai K; Majima Y; Tanikawa K
Gan No Rinsho; 1987 Feb; 33(2):205-10. PubMed ID: 3031334
[TBL] [Abstract][Full Text] [Related]
24. Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.
Sasaki M; Matsubara T; Kakuda Y; Sato Y; Nakanuma Y
Am J Surg Pathol; 2014 Mar; 38(3):364-9. PubMed ID: 24487593
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
[TBL] [Abstract][Full Text] [Related]
26. Cholangiolocellular carcinoma of the liver: imaging findings.
Motosugi U; Ichikawa T; Nakajima H; Araki T; Matsuda M; Suzuki T; Fujii H; Nakazawa T; Yamaguchi H
J Comput Assist Tomogr; 2009; 33(5):682-8. PubMed ID: 19820492
[TBL] [Abstract][Full Text] [Related]
27. Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) originating from hepatic progenitor cell: a case report and review of the literature.
Hu J; Yuan R; Huang C; Shao J; Zou S; Wang K
World J Surg Oncol; 2016 Aug; 14(1):218. PubMed ID: 27535234
[TBL] [Abstract][Full Text] [Related]
28. Variant differentiation patterns in primary liver carcinoma.
Sempoux C; Paradis V; Saxena R
Semin Diagn Pathol; 2017 Mar; 34(2):176-182. PubMed ID: 28256363
[TBL] [Abstract][Full Text] [Related]
29. [Resection of cholangiolocellular carcinoma successfully responding to neoadjuvant hepatic arterial infusion chemotherapy - report of a case].
Nakayama Y; Nakamura N; Ito T; Matsubayashi J; Yogo A; Kitou Y; Hanamoto K; Ura K; Taira K; Oe H; Yoshikawa A; Mitsuyoshi A; Ishigami S; Shirase T; Doi R
Gan To Kagaku Ryoho; 2012 Jul; 39(7):1155-7. PubMed ID: 22790060
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological significance of 'subtypes with stem-cell feature' in combined hepatocellular-cholangiocarcinoma.
Sasaki M; Sato H; Kakuda Y; Sato Y; Choi JH; Nakanuma Y
Liver Int; 2015 Mar; 35(3):1024-35. PubMed ID: 24712771
[TBL] [Abstract][Full Text] [Related]
31. NTP Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 Apr; 450():1-321. PubMed ID: 12594525
[TBL] [Abstract][Full Text] [Related]
32. Plant-derived nanoparticle treatment with cocc 30c ameliorates attention and motor abilities in sleep-deprived rats.
Zubedat S; Freed Y; Eshed Y; Cymerblit-Sabba A; Ritter A; Nachmani M; Harush R; Aga-Mizrachi S; Avital A
Neuroscience; 2013 Dec; 253():1-8. PubMed ID: 23973403
[TBL] [Abstract][Full Text] [Related]
33. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
34. Yolk sac tumor of the liver combined with hepatocellular carcinoma.
Morinaga S; Nishiya H; Inafuku T
Arch Pathol Lab Med; 1996 Jul; 120(7):687-90. PubMed ID: 8757478
[TBL] [Abstract][Full Text] [Related]
35. Hepatocellular adenoma. Its transformation to carcinoma in a user of oral contraceptives.
Tesluk H; Lawrie J
Arch Pathol Lab Med; 1981 Jun; 105(6):296-9. PubMed ID: 6263214
[TBL] [Abstract][Full Text] [Related]
36. A case of primary biliary cirrhosis that complicated with combined hepatocellular and cholangiocellular carcinoma.
Kobayashi M; Furuta K; Kitamura H; Oguchi K; Arai M; Koike S; Nakazawa K
Clin J Gastroenterol; 2011 Aug; 4(4):236-241. PubMed ID: 26189527
[TBL] [Abstract][Full Text] [Related]
37. Hepatic stem and progenitor cells in liver diseases and hepatocarcinogenesis.
Heim D; Wege H
Minerva Gastroenterol Dietol; 2009 Jun; 55(2):111-21. PubMed ID: 19305371
[TBL] [Abstract][Full Text] [Related]
38. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma.
Roskams T
Oncogene; 2006 Jun; 25(27):3818-22. PubMed ID: 16799623
[TBL] [Abstract][Full Text] [Related]
39. Clear cell carcinoma of the liver: a case report.
Kilinç N; Yalçin K; Değertekin H; Ozaydin M
Turk J Gastroenterol; 2003 Sep; 14(3):211-4. PubMed ID: 14655070
[TBL] [Abstract][Full Text] [Related]
40. Architectural and immunohistochemical characterization of biliary ductules in normal human liver.
Dezso K; Paku S; Papp V; Turányi E; Nagy P
Stem Cells Dev; 2009 Dec; 18(10):1417-22. PubMed ID: 19552603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
